CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
Go back to CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.01 +0.03 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.98 | 52 Week High | $24.68 | |||
| Open | $2.98 | 52 Week Low | $9.10 | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $2.96 | EPS | $0.00 | |||
| Volume | 2,050,210 | |||||
